Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.30

ALT Q3 2016 Earnings — Altimmune, Inc. Revenue & Financial Results | Market Cap Arena

ALTAltimmune, Inc.

$335M

Q3 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$993,885

Gross Profit

-$1M-141.6% margin

Operating Income

-$4M-401.4% margin

Net Income

$109M10990.7% margin

EPS (Diluted)

$-21.30

QoQ Revenue Growth

-52.9%

Cash Flow

Operating Cash Flow

$111M

Free Cash Flow

$111M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$141M

Total Liabilities

$4M

Stockholders' Equity

$136M

Cash & Equivalents

$69M

← FY 2016 All Quarters Q4 2016 →